AMPLY raises £1.3m seed led by Twin Path Ventures to accelerate drug discovery for aggressive cancers and superbugs

AMPLY builds an AI driven drug discovery platform that combines computational biology, sequencing and lab validation to develop new treatments for aggressive cancers and drug resistant infections.